Company

We are GSK

As a focused biopharma company, we discover, develop and deliver medicines and vaccines to create value for patients and shareholders. We aim to positively impact the health of 2.5 billion people by the end of the decade.

Bringing innovation to patients, better and faster

Close video

Behind the science US edition

Understanding multiple myeloma: A visual guide

This article breaks down multiple myeloma in a simple, visual format.

Redefining aging with senior athletes

A national TV special inspiring older adults to join the health revolution and know their risk for RSV, hosted by Angela Bassett.

elderly woman sitting in her living room.

Managing inflammation for COPD and asthma

GSK has led in pulmonary disease treatment for 50+ years, advancing the genetics of respiratory illness.

Surviving the storm: A family's battle with rotavirus

Remon Abu-Elyazeed life was transformed as his five-month-old son, Ramy, battled severe rotavirus gastroenteritis.

Advancing possibilities for severe asthma

We are advancing how respiratory conditions are treated with options that may provide sustained disease management.

Meet Rachel: A vaccine epidemiologist

Get to know an epidemiologist who spends her days studying viruses and vaccines to help make the world a healthier place.

The role of biomarkers and genetics in ovarian cancer: Five facts

Every five minutes, someone's life changes with a gynecological cancer diagnosis

Renuka working in office in front of her computer.

Meet Renuka: A principal scientist fighting infectious diseases

Renuka’s life-long journey shows how a love for science can turn into important work that helps people all over the world.

Investors

We announced our full year and fourth quarter 2025 results on Wednesday, 4 February.

Visit our global website for latest results

Press releases

View all press releases

Two employees discussing work in the office

GSK Global links